October 9, 2017
ThromboGenics publishes data on Diabetic Retinopathy possible therapy
ThromboGenics’s preclinical data on its THR-317 have been published in Experimental Eye Research, the company said on Monday.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
October 9, 2017
AstraZeneca’s Tagrisso gets BTD for certain lung cancer
AstraZeneca Monday said that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the…
October 9, 2017
Chemistry Nobel prize
The 2017 Nobel Prize in chemistry has been awarded to three scientists who developed a technique called cryo-electron microscopy (Cryo-EM), which simplifies…
October 6, 2017
New vice president for Sobi
Swedish Orphan Biovitrum AB (publ) (Sobi) has appointed Norbert Oppitz as Senior Vice President for the newly established business area Specialty Care.
October 5, 2017
Tigenix to present positive Chron’s disease treatment testing results in Florida, USA
TiGenix NV has achieved positive results from its ADMIRE-CD Phase III clinical trial of Cx601 for the treatment of complex perianal…
October 4, 2017
FDA simplifies Institutional Review Board review requirements for physicians seeking patient expanded access
FDA has announced updates to three final guidances, including Form FDA 3926 and its instructions, to simplify Institutional Review Board (IRB)…
October 4, 2017
Timing of oral dosing relative to meals drove the lower than expected drug exposures
Data presented by Tetraphase Pharmaceuticals at IDWeek confirmed that the timing of oral dosing relative to meals drove the lower…
October 4, 2017
Gilead, MPP: single-tablet regimen has potential to simplify the management of HIV
The Medicines Patent Pool (MPP) today announced a licence with Gilead Sciences for bictegravir (BIC), now under review in the United…
October 4, 2017
OptiBiotix Health launches SlimBiome and LPLDL
OptiBiotix Health has kicked off with its SlimBiome and LPLDL products at Supply Side West in Las Vegas, in late September 2017.
October 4, 2017
Evgen Pharma gets first European manufacturing patent
Evgen Pharma got the grant of the first European patent for its lead product, SFX-01.